VAERS reports by lot

GSK Varicella/Shingles lot 95LX9: VAERS reports

43 VAERS reports list lot 95LX9 as a GSK Varicella/Shingles vaccine, received between 2018-07-24 and 2019-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
5%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5731%
Injection-site / Local reaction4022%
Musculoskeletal2715%
Neurological2312%
Dermatological (non-injection-site)126%
Cardiac / Cardiovascular84%
Gastrointestinal74%
Allergic / Anaphylactic53%
Respiratory32%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Vermont5
Pennsylvania3
Iowa3
Wisconsin3
Illinois2
California2
Texas2
Florida2
New Jersey2
New Hampshire2
Colorado1

Reports by month received

2018-075
2018-0812
2018-099
2018-106
2018-118
2019-031
2019-072

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.